| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |